Join to View Full Profile
500 Ray C Hunt DrCharlottesville, VA 22903
Phone+1 434-924-2224
Fax+1 434-244-9481
Dr. Greene is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified urologic cancer surgeon and Chair of the Department of Urology at the University of Virginia. My interests include robotic surgery, prostate cancer outcomes and imaging, and medical education.
Education & Training
UCSFM.A.S., Clinical Research, 2006 - 2008
University of California (San Francisco)Residency, Urology, 2002 - 2006- University of California (San Francisco)Residency, Surgery, 2000 - 2002
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2026
VA State Medical License 2019 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsTrends in Urology Residency Applications: Results From the American Urological Association Medical Student Survey From 2022 to 2024.Michael Creswell, Kirsten Greene, Lee Richstone, Simone Thavaseelan, Erica Traxel
Urology. 2025-02-04 - Trends in Urology Residency Applications: Results From The Society of Academic Urologists Program Director Survey From 2022 to 2024.Michael Creswell, Kirsten Greene, Lee Richstone, Simone Thavaseelan, Erica Traxel
Urology. 2024-12-17 - 1 citationsThe Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and Recommendations.Jennifer Taylor, Sagar Patel, Krishnanath Gaitonde, Kirsten Greene, Joseph C Liao
Current Oncology. 2024-10-28
Journal Articles
- First-in-Human Phase I Study of CTT1057, a Novel 18F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate CancerSpencer C Behr, Hao G Nguyen, Thomas A Hope, Kirsten L Greene, Matthew R Cooperberg, Robert R Flavell, Eric J Small, Peter R Carroll, Journal of Nuclear Medicine
Press Mentions
New Test Locates Prostate Cancer’s SpreadJanuary 6th, 2021- New Scan Finds Prostate Cancer Cells Hiding in the BodyDecember 16th, 2020
Thanks. Feedback Improves Google AdsOctober 16th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
